Search
Filter Results
- Resource Type
- Article1
- Book1
- Book Digital1
- Article Type
- Research Support, U.S. Gov't, P.H.S.1
- Result From
- Lane Catalog1
- PubMed1
-
Year
- Journal Title
- Biochemistry1
Search Results
Sort by
- BookDigital Access ScienceDirect v. 1219-1220, 1223, 1225-1226, 1228-1230, 1232-1242, 1244-1304, 2001-07.Access via Advances in planned parenthood Advances in tumour prevention, detection and characterization 1974-1980 Birth defects, Original article series Cancer chemotherapy, challenges for the future Excerpta medica Gastrointestinal function Proceedings of the European Dialysis and Transplantation Association Proceedings of the European Society for the Study of Drug ToxicityLocationVersionCall NumberItemsCall number varies. Search for International congress series to find individual volumes of this title.
- ArticleBearer CF, Neet KE.Biochemistry. 1978 Aug 22;17(17):3512-6.Both activities of the aspartokinase--homoserine I (AK-HSD) of Escherichia coli are inhibited by threonine. Careful threonine binding studies have now been done which have allowed us to distinguish the various effects of threonine on the enzyme. The ultrafiltration technique of H. Paulus ((1969) Anal. Biochem. 32, 101) for measuring ligand binding was shown to be comparable with equilibrium dialysis techniques. Reduction in error by utilization of this procedure enabled us to obtain evidence for two different sets of threonine sites by direct binding studies. The binding data were mathematically consistent with two independent classes of threonine sites, each of which contained four sites per tetramer and had a Hill coefficient of about 2.3--2.5. KD for the second set of sites was five- to tenfold greater than the high affinity sites, depending upon conditions. The data now suggest that the sequential model for site--site interactions adequately describes the cooperativity of threonine binding to the high affinity set of sites.